Literature DB >> 24709443

Cell-based drug testing; this world is not flat.

David W Grainger1.   

Abstract

Mesh：

Year:  2014        PMID： 24709443     DOI： 10.1016/j.addr.2014.04.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


× No keyword cloud information.
  6 in total

Review 1.  MiRNA inhibition in tissue engineering and regenerative medicine.

Authors:  Kelsey R Beavers; Christopher E Nelson; Craig L Duvall
Journal:  Adv Drug Deliv Rev       Date:  2014-12-29       Impact factor: 15.470

2.  Three Dimensional Culture of Human Renal Cell Carcinoma Organoids.

Authors:  Cynthia A Batchelder; Michele L Martinez; Nadire Duru; Frederick J Meyers; Alice F Tarantal
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

Review 3.  Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models.

Authors:  Silvia Caddeo; Monica Boffito; Susanna Sartori
Journal:  Front Bioeng Biotechnol       Date:  2017-07-26

4.  A versatile modular bioreactor platform for Tissue Engineering.

Authors:  Sebastian Schuerlein; Thomas Schwarz; Steffan Krziminski; Sabine Gätzner; Anke Hoppensack; Ivo Schwedhelm; Matthias Schweinlin; Heike Walles; Jan Hansmann
Journal:  Biotechnol J       Date:  2016-09-26       Impact factor: 4.677

5.  Validation of in vitro assays in three-dimensional human dermal constructs.

Authors:  Ayesha Idrees; Valeria Chiono; Gianluca Ciardelli; Siegfried Shah; Richard Viebahn; Xiang Zhang; Jochen Salber
Journal:  Int J Artif Organs       Date:  2018-05-29       Impact factor: 1.595

6.  Novel dual-flow perfusion bioreactor for in vitro pre-screening of nanoparticles delivery: design, characterization and testing.

Authors:  Maria Elena Lombardo; Francesco Carfì Pavia; Emanuela Fabiola Craparo; Elisa Capuana; Gennara Cavallaro; Valerio Brucato; Vincenzo La Carrubba
Journal:  Bioprocess Biosyst Eng       Date:  2021-07-25       Impact factor: 3.210
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.